The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation

Debolina Ray, Keith R. Murphy, Susannah Gal

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight different breast cancer cell lines, with either wild-type or mutant p53 protein, in response to oxidative stress. We found that the wild-type p53 protein from MCF-7 and ZR-75-1 cells binds with different affinity to 12 gene sequences covering several pathways regulated by p53. Treatment of MCF-7 cells with H2O2 caused an increase in this binding affinity while this same treatment of ZR-75-1 cells caused the p53 protein to lose binding affinity to several genes. The mutant p53 proteins from all cell lines had minimal to weak binding to these sequences even after treatment with H2O2. The p53 protein from the ZR-75-1 cells and three cell lines with mutant p53 showed serine 15 phosphorylated protein, but we found no correlation between that modification and the levels or localization of this protein although DNA binding affinity of wild-type protein might be affected by this modification. From this and other work, it appears that the mutation status of the TP53 gene alone cannot predict the activity of this tumor suppressor since cell lines with the same genetic information do not show the same properties of this protein.

Original languageEnglish (US)
Pages (from-to)848-857
Number of pages10
JournalCancer Biology and Therapy
Volume13
Issue number10
DOIs
StatePublished - Aug 1 2012

Fingerprint

Serine
Phosphorylation
Breast Neoplasms
Cell Line
DNA
Proteins
Mutant Proteins
Tumor Suppressor Proteins
p53 Genes
MCF-7 Cells
DNA-Binding Proteins
Post Translational Protein Processing
Genes
Oxidative Stress
Mutation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

@article{c0141731486142d9a4365aaa3c0e14cf,
title = "The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation",
abstract = "Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight different breast cancer cell lines, with either wild-type or mutant p53 protein, in response to oxidative stress. We found that the wild-type p53 protein from MCF-7 and ZR-75-1 cells binds with different affinity to 12 gene sequences covering several pathways regulated by p53. Treatment of MCF-7 cells with H2O2 caused an increase in this binding affinity while this same treatment of ZR-75-1 cells caused the p53 protein to lose binding affinity to several genes. The mutant p53 proteins from all cell lines had minimal to weak binding to these sequences even after treatment with H2O2. The p53 protein from the ZR-75-1 cells and three cell lines with mutant p53 showed serine 15 phosphorylated protein, but we found no correlation between that modification and the levels or localization of this protein although DNA binding affinity of wild-type protein might be affected by this modification. From this and other work, it appears that the mutation status of the TP53 gene alone cannot predict the activity of this tumor suppressor since cell lines with the same genetic information do not show the same properties of this protein.",
author = "Debolina Ray and Murphy, {Keith R.} and Susannah Gal",
year = "2012",
month = "8",
day = "1",
doi = "10.4161/cbt.20835",
language = "English (US)",
volume = "13",
pages = "848--857",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "10",

}

The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation. / Ray, Debolina; Murphy, Keith R.; Gal, Susannah.

In: Cancer Biology and Therapy, Vol. 13, No. 10, 01.08.2012, p. 848-857.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation

AU - Ray, Debolina

AU - Murphy, Keith R.

AU - Gal, Susannah

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight different breast cancer cell lines, with either wild-type or mutant p53 protein, in response to oxidative stress. We found that the wild-type p53 protein from MCF-7 and ZR-75-1 cells binds with different affinity to 12 gene sequences covering several pathways regulated by p53. Treatment of MCF-7 cells with H2O2 caused an increase in this binding affinity while this same treatment of ZR-75-1 cells caused the p53 protein to lose binding affinity to several genes. The mutant p53 proteins from all cell lines had minimal to weak binding to these sequences even after treatment with H2O2. The p53 protein from the ZR-75-1 cells and three cell lines with mutant p53 showed serine 15 phosphorylated protein, but we found no correlation between that modification and the levels or localization of this protein although DNA binding affinity of wild-type protein might be affected by this modification. From this and other work, it appears that the mutation status of the TP53 gene alone cannot predict the activity of this tumor suppressor since cell lines with the same genetic information do not show the same properties of this protein.

AB - Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight different breast cancer cell lines, with either wild-type or mutant p53 protein, in response to oxidative stress. We found that the wild-type p53 protein from MCF-7 and ZR-75-1 cells binds with different affinity to 12 gene sequences covering several pathways regulated by p53. Treatment of MCF-7 cells with H2O2 caused an increase in this binding affinity while this same treatment of ZR-75-1 cells caused the p53 protein to lose binding affinity to several genes. The mutant p53 proteins from all cell lines had minimal to weak binding to these sequences even after treatment with H2O2. The p53 protein from the ZR-75-1 cells and three cell lines with mutant p53 showed serine 15 phosphorylated protein, but we found no correlation between that modification and the levels or localization of this protein although DNA binding affinity of wild-type protein might be affected by this modification. From this and other work, it appears that the mutation status of the TP53 gene alone cannot predict the activity of this tumor suppressor since cell lines with the same genetic information do not show the same properties of this protein.

UR - http://www.scopus.com/inward/record.url?scp=84864533044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864533044&partnerID=8YFLogxK

U2 - 10.4161/cbt.20835

DO - 10.4161/cbt.20835

M3 - Article

C2 - 22785213

AN - SCOPUS:84864533044

VL - 13

SP - 848

EP - 857

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 10

ER -